{"id":19154,"date":"2018-03-27T14:39:00","date_gmt":"2018-03-27T21:39:00","guid":{"rendered":"https:\/\/sop.washington.edu\/?p=19154"},"modified":"2026-04-01T13:24:36","modified_gmt":"2026-04-01T20:24:36","slug":"barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers","status":"publish","type":"post","link":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/","title":{"rendered":"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n

\"\"<\/p>\n

When a project is moments away from completion, or a new question arises during the experiment, a little bit of extra funding can go a long way. This is the inspiration behind the ITHS Catalyst program<\/a>. This pilot award is designed to provide investigators with \u201cjust-in-time\u201d resources of up to $5,000. For Melissa, the ITHS Catalyst Award provided her the funds needed to extend her experiment just long enough to collect data that better reflected the clinically-relevant time period she was hoping to study.<\/p>\n<\/div>\n<\/div>\n

\n
\"\"
Dr. Melissa Barker-Haliski <\/figcaption><\/figure>\n

Melissa Barker-Haliski, PhD<\/a>, research assistant professor in the Department of Pharmacy conducts preclinical research in the evaluation and characterization of investigational therapies for epilepsy in special patient populations, including elderly patients. While there are many antiseizure drugs on the market for epilepsy, little information is available to compare the effectiveness of these therapies with older populations. Furthermore, researchers are starting to see that seizures and epilepsy are frequently present among those with Alzheimer\u2019s disease. Melissa\u2019s research aims to better understand this relationship so that one can investigate how antiseizure medications could affect the health of the Alzheimer\u2019s disease patient population.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
Preclinical antiseizure drug development is predominately conducted in rodent seizure and epilepsy models. \u00a0Melissa studies the impact of seizures on a mouse model of familial early-onset Alzheimer\u2019s disease. Human patients with familial early-onset Alzheimer\u2019s disease begin to show neurodegenerative symptoms in mid-life (40- to 50-years-old). By extending her experiment a few months, Melissa was able to collect pilot data when the mice were of a physiological age that more closely reflects when symptoms of Alzheimer\u2019s disease are likely to be show up in humans.<\/div>\n
\n
\n
\n

\u201cWe know that people with Alzheimer\u2019s are having these seizures, but we don\u2019t know how it effects their outcomes\u201d
\n\u2013Dr. Melissa Barker-Haliski, UW School of Pharmacy<\/p>\n<\/blockquote>\n

With ITHS funds, she can take a closer look to engage this question by collecting essential data. “Without Catalyst funds, I would not have been able to age the animals to the time point that was most relevant to Alzheimer\u2019s disease, she remarked.”<\/p>\n<\/div>\n<\/div>\n

The experiment would have simply ended before the mice could reach that pivotal age. \u201cThis support has been very useful to the launch of my independent research.\u201d<\/div>\n
\n
\n

Melissa used this data to submit an application for further funding through the UW Royal Research Fund. Her newly-funded research will examine how chronic seizures in a similar cohort of mice with the Alzheimer\u2019s disease-associated genetic mutation will impact cognition. She will demonstrate how chronic seizures affect the development of symptoms associated with Alzheimer\u2019s disease. This data can then be compared to cognitive performance of age-matched mice who have not had chronic seizures. With an improved understanding of how seizures impact the evolution of Alzheimer\u2019s disease, further study can be conducted on ways to treat the disease\u2019s symptoms, and someday even slow its escalation.<\/p>\n

The Catalyst award is intended to instigate new research directions and encourage further study in a given area. According to Dr. Barker-Haliski, this is precisely what has happened: \u201cthe initial ITHS funded project has been instrumental in furthering my work \u2013 I have been using this pilot data to submit grants left and right.\u201d Working with ITHS has also enabled Melissa to deepen her capacity for collaboration with other departments on campus; by publishing this data, the research team can continue to pursue larger grants that will likely inform on the therapeutic management of seizures in Alzheimer\u2019s disease.<\/p>\n

 <\/p>\n

Original story<\/a> published on the Institute for Translational Health Sciences website and shared with here with permission.<\/p>\n

Advance your career in scientific and outcomes\u00a0research at the University of Washington School of Pharmacy. Learn more\u00a0about our Graduate (PhD and MS) degree programs<\/a>.<\/h4>\n

Link to Department of Pharmacy archived news<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

When a project is moments away from completion, or a new question arises during the experiment, a little bit of extra funding can go a long way. This is the inspiration behind the ITHS Catalyst…<\/p>\n","protected":false},"author":3,"featured_media":14509,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[],"class_list":["post-19154","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmacy-news"],"yoast_head":"\nBarker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s - School of Pharmacy<\/title>\n<meta name=\"description\" content=\"When a project is moments away from completion, or a new question arises during the experiment, a little bit of extra funding can go a long way. This is\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s - School of Pharmacy\" \/>\n<meta property=\"og:description\" content=\"When a project is moments away from completion, or a new question arises during the experiment, a little bit of extra funding can go a long way. This is\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/\" \/>\n<meta property=\"og:site_name\" content=\"School of Pharmacy\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/UWSOP\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-27T21:39:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-01T20:24:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/haliski_melissa-620x868.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"1400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tim Wentzel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:site\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tim Wentzel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/\"},\"author\":{\"name\":\"Tim Wentzel\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/person\\\/21859bae0c32073fc2c8d833a054b09f\"},\"headline\":\"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s\",\"datePublished\":\"2018-03-27T21:39:00+00:00\",\"dateModified\":\"2026-04-01T20:24:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/\"},\"wordCount\":650,\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/haliski_melissa-620x868.jpg\",\"articleSection\":[\"Pharmacy News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/\",\"name\":\"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s - School of Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/haliski_melissa-620x868.jpg\",\"datePublished\":\"2018-03-27T21:39:00+00:00\",\"dateModified\":\"2026-04-01T20:24:36+00:00\",\"description\":\"When a project is moments away from completion, or a new question arises during the experiment, a little bit of extra funding can go a long way. This is\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/haliski_melissa-620x868.jpg\",\"contentUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/haliski_melissa-620x868.jpg\",\"width\":1000,\"height\":1400,\"caption\":\"Dr. Melissa Barker-Haliski\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"name\":\"University of Washington School of Pharmacy\",\"description\":\"University of Washington\",\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"alternateName\":\"UW School of Pharmacy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\",\"name\":\"University of Washington School of Pharmacy\",\"alternateName\":\"UW School of Pharmacy\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"contentUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"width\":526,\"height\":527,\"caption\":\"University of Washington School of Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/UWSOP\",\"https:\\\/\\\/x.com\\\/UW_Pharmacy\",\"https:\\\/\\\/www.instagram.com\\\/uw_pharmacy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UWPharmacySchool\",\"https:\\\/\\\/www.linkedin.com\\\/groups\\\/3820716\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/person\\\/21859bae0c32073fc2c8d833a054b09f\",\"name\":\"Tim Wentzel\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s - School of Pharmacy","description":"When a project is moments away from completion, or a new question arises during the experiment, a little bit of extra funding can go a long way. This is","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/","og_locale":"en_US","og_type":"article","og_title":"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s - School of Pharmacy","og_description":"When a project is moments away from completion, or a new question arises during the experiment, a little bit of extra funding can go a long way. This is","og_url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/","og_site_name":"School of Pharmacy","article_publisher":"http:\/\/www.facebook.com\/UWSOP","article_published_time":"2018-03-27T21:39:00+00:00","article_modified_time":"2026-04-01T20:24:36+00:00","og_image":[{"width":1000,"height":1400,"url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/haliski_melissa-620x868.jpg","type":"image\/jpeg"}],"author":"Tim Wentzel","twitter_card":"summary_large_image","twitter_creator":"@UW_Pharmacy","twitter_site":"@UW_Pharmacy","twitter_misc":{"Written by":"Tim Wentzel","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/#article","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/"},"author":{"name":"Tim Wentzel","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/person\/21859bae0c32073fc2c8d833a054b09f"},"headline":"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s","datePublished":"2018-03-27T21:39:00+00:00","dateModified":"2026-04-01T20:24:36+00:00","mainEntityOfPage":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/"},"wordCount":650,"publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/#primaryimage"},"thumbnailUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/haliski_melissa-620x868.jpg","articleSection":["Pharmacy News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/","name":"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s - School of Pharmacy","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/#primaryimage"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/#primaryimage"},"thumbnailUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/haliski_melissa-620x868.jpg","datePublished":"2018-03-27T21:39:00+00:00","dateModified":"2026-04-01T20:24:36+00:00","description":"When a project is moments away from completion, or a new question arises during the experiment, a little bit of extra funding can go a long way. This is","breadcrumb":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/#primaryimage","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/haliski_melissa-620x868.jpg","contentUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/haliski_melissa-620x868.jpg","width":1000,"height":1400,"caption":"Dr. Melissa Barker-Haliski"},{"@type":"BreadcrumbList","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/barker-haliski-advances-research-in-antiseizure-therapies-in-patients-with-alzheimers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/"},{"@type":"ListItem","position":2,"name":"Barker-Haliski advances research in antiseizure therapies in patients with Alzheimer’s"}]},{"@type":"WebSite","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","name":"University of Washington School of Pharmacy","description":"University of Washington","publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"alternateName":"UW School of Pharmacy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization","name":"University of Washington School of Pharmacy","alternateName":"UW School of Pharmacy","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/","url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","contentUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","width":526,"height":527,"caption":"University of Washington School of Pharmacy"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/UWSOP","https:\/\/x.com\/UW_Pharmacy","https:\/\/www.instagram.com\/uw_pharmacy\/","https:\/\/www.youtube.com\/user\/UWPharmacySchool","https:\/\/www.linkedin.com\/groups\/3820716"]},{"@type":"Person","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/person\/21859bae0c32073fc2c8d833a054b09f","name":"Tim Wentzel"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts\/19154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/comments?post=19154"}],"version-history":[{"count":0,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts\/19154\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media\/14509"}],"wp:attachment":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media?parent=19154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/categories?post=19154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/tags?post=19154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}